{
  "docId": "019dd923-5e88-73ef-bd5b-b0f1f6743c2e",
  "docSlug": "6ecc16685376d74d",
  "documentTitle": "barclays disruptive technologies conference bayer crop science handout 2024.06.11",
  "authorId": "Barclays",
  "authorName": "Bayer",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "equity_research",
  "sourceTypeLabel": "Equity research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 14,
  "pageCount": 20,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "The slide uses a split-screen approach to contrast market-wide growth with company-specific growth targets.",
  "elementsJson": [
    "headline_text",
    "bar_chart_stacked",
    "icon_grid",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5b-b0f1f6743c2e/14",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5b-b0f1f6743c2e",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5b-b0f1f6743c2e.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5b-b0f1f6743c2e#slide-14",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "We aim to Outgrow the Market with a 17% CAGR",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-103e-75c4-b715-a068395b9c22",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.35,
        "x": 0.08,
        "y": 0.23
      },
      "kind": "chart",
      "text": "Global Biologicals Market growth from €12bn in 2022 to €30bn in 2035 at 7% CAGR",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c005cc5-20e6-4991-b4ef-ef29daffd11b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.52,
        "y": 0.6
      },
      "kind": "list",
      "text": "In-licensing or distribution; Pipeline advancements; Strategic research partnerships",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "87b88be8-91d4-48cf-8b5b-fb305a250b8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.55,
        "y": 0.3
      },
      "kind": "metric",
      "text": "Bayer growth from €200m to >€1.5bn at 17% CAGR",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4fc7be82-64c1-4c0f-a056-44057a046500",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "CAGR: 17%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-103e-75c4-b715-a6cbc7674fed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.52,
        "y": 0.84
      },
      "kind": "paragraph",
      "text": "Increasingly stringent regulatory approvals processes, consumers' demand for low- and no-residue food products and retailer food sourcing standards drive growers to look for new innovations in crop protection",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0110f2f0-eedd-4b7a-9d8f-1e9823a4a919",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.08,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Source: Global Agricultural Biologicals Market, Forecast to 2030, Frost & Sullivan, 2022 and internal estimates",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c6e0e54f-bea7-4328-ad63-84e75e81866f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.08,
        "y": 0.15
      },
      "kind": "title",
      "text": "We aim to Outgrow the Market with a 17% CAGR",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8dac76f2-b15c-407a-aa62-229e98cd9c9a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.08,
        "y": 0.08
      },
      "kind": "title",
      "text": "Biologicals Market Expected to More than Double to €30bn by 2035",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bee57a88-93a9-4797-919e-1124936ce8bf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Contrast Pairs",
      "slug": "contrast-pairs",
      "agent": "Storyteller",
      "layer": "loop",
      "matchId": "019dd95a-1970-727c-8b76-78c6e85ae5cf",
      "evidence": "Two-panel split: Global Biologicals Market (left) vs Bayer Biologicals Opportunity (right).",
      "confidence": 70
    },
    {
      "name": "Goal Gradient Effect",
      "slug": "goal-gradient-effect",
      "agent": "Storyteller",
      "layer": "loop",
      "matchId": "019dd95a-1970-727c-8b76-75519062f984",
      "evidence": "Frames a 13-year growth path with explicit progress markers (CAGR arrows).",
      "confidence": 60
    },
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "019dd95a-1970-727c-8b76-6ad0be3ee8f3",
      "evidence": "Title 'Biologicals Market Expected to More than Double to €30bn by 2035' is an insight headline.",
      "confidence": 90
    },
    {
      "name": "Concrete Language",
      "slug": "concrete-language",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "019dd95a-1970-727c-8b76-6e24d93301ac",
      "evidence": "Specific: €12bn 2022 → €30bn 2035, 7% market CAGR, Bayer 17% CAGR €200m → >€1.5bn.",
      "confidence": 88
    },
    {
      "name": "Thesis archetype",
      "slug": "thesis-archetype",
      "agent": null,
      "layer": "slide",
      "matchId": "82a34f74-9347-4505-b921-86ec462896f2",
      "evidence": "We aim to Outgrow the Market with a 17% CAGR",
      "confidence": 0.5
    },
    {
      "name": "Visual Hierarchy",
      "slug": "visual-hierarchy",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "019dd95a-1970-727c-8b76-725cee7e8033",
      "evidence": "Stacked bars on left and bold €200m / €1.5bn / 17% on right dominate.",
      "confidence": 75
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 16,
      "from": 14,
      "beatId": "019dd95a-07a7-7579-bd60-bd6ca00543ab",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Biologicals doubling, regen-ag pathway, reach scaling 340m → >400m acres",
      "position": 5,
      "confidence": 78,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    },
    {
      "to": 16,
      "from": 14,
      "beatId": "019dd95a-07a7-7579-bd60-d3700101a7ab",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "New Bliss",
      "beatSlug": "sparkline-new-bliss",
      "evidence": "Regen ag on >400m acres with biologicals + data backbone",
      "position": 5,
      "confidence": 55,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 16,
      "from": 14,
      "name": "Three Horizons",
      "slug": "49-three-horizons",
      "bestFor": "Innovation strategy, long-term planning, board presentations",
      "matchId": "019dd95a-08f7-737a-a005-859bf58ed1af",
      "evidence": "p14 emerging biologicals doubling to €30bn, p15 data/digital platform, p16 future reach >400m acres mid-next-decade — read as H2/H3 around the H1 pipeline.",
      "position": 5,
      "objective": "Position adjacent and longer-horizon bets behind the core",
      "structure": "Horizon 1 (Core Business) -> Horizon 2 (Emerging Opportunities) -> Horizon 3 (Future Bets) -> Balanced Portfolio",
      "confidence": 65,
      "description": "Structure initiatives across time horizons: protect core, grow adjacencies, create futures"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}